NCT04571515View on ClinicalTrials.gov

Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain

PHASE2CompletedINTERVENTIONAL

Enrollment

114

Participants

Timeline

Start Date

September 29, 2020

Primary Completion Date

December 15, 2020

Study Completion Date

December 22, 2020

Conditions

PainPostoperative PainPain, Acute

Interventions

DRUG

MR-107A-01

Oral tablet

DRUG

Placebo

Oral tablet

Trial Locations (1)

84107

Research Facility 101, Salt Lake City

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mylan Inc.

INDUSTRY